• 1
    Waller P, Shaw M, Ho D, Shakir S, Ebrahim S. Hospital admissions for ‘drug-induced’ disorders in England: a study using the Hospital Episodes Statistics (HES) database. Br J Clin Pharmacol 2005; 59: 2139.
  • 2
    Davis S, Raine JM. Spontaneous reporting—UK. In Pharmacovigilance, eds MannR, AndrewsE. New York: Wiley 2002; 195207.
  • 3
    Stephens MDB. Introduction. In Stephens’ Detection of New Adverse Drug Reactions, eds TalbotJ, WallerP. Chichester: Wiley 2004; 1017.
  • 4
    Mittmann N, Knowles SR, Gomez M, Fish JS, Cartotto R, Shear NH. Evaluation of the extent of under-reporting of serious adverse drug reactions: the case of toxic epidermal necrolysis. Drug Safety 2004; 27: 47787.
  • 5
    Backstrom M, Mjorndal T, Dahlqvist R. Under-reporting of serious adverse drug reactions in Sweden. Pharmacoepidemiol Drug Saf 2004; 13: 4837.
  • 6
    Begaud B, Martin K, Haramburu F, Moore N. Rates of spontaneous reporting of adverse drug reactions in France. Jama 2002; 288: 1588.
  • 7
    Heeley E, Riley J, Layton D, Wilton LV, Shakir SA. Prescription-event monitoring and reporting of adverse drug reactions. Lancet 2001; 358 (9296): 18723.
  • 8
    Alvarez-Requejo A, Carvajal A, Begaud B, Moride Y, Vega T, Arias LH. Under-reporting of adverse drug reactions. Estimate based on a spontaneous reporting scheme and a sentinel system. Eur J Clin Pharmacol 1998; 54: 4838.
  • 9
    Smith CC, Bennett PM, Pearce HM, Harrison PI, Reynolds DJ, Aronson JK, Grahame-Smith DG. Adverse drug reactions in a hospital general medical unit meriting notification to the Committee on Safety of Medicines. Br J Clin Pharmacol 1996; 42: 4239.
  • 10
    Brown EG, Wood L, Wood S. The medical dictionary for regulatory activities (MedDRA). Drug Safety 1999; 20: 10917.
  • 11
    Office of National Statistics. 2001 census data. Available at: (accessed 22 March 2005).